It's been a while and I've been reading many of the posts on Mesoblast. Always entertaining...
Looking back at the market cap history of this stock and in light of the impending pipeline of news it's fair to say the turnaround is in full swing.
Forget price atm. Purely looking at market cap it's coming off a rock bottom base of ~A300m over the last few months and it now sits at ~$630m. I must admit I need to update the chart below but it's clear there is significant ground to make up.
The pipeline of news has multiple catalysts with the biggest being validation of the science by the FDA.
I recall a market cap of well over $2B in the last major run during 2019-2020.
All signs point to a similar scenario as the company seeks approval in the US.
GLTA
Valuation
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
-0.035(3.23%) |
Mkt cap ! $1.184B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.12 | $1.02 | $19.96M | 19.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 51913 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 70488 | 13 |
View Market Depth
| Last trade - 13.42pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
-0.035 ( 3.14 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.12 | $1.02 | 2134339 | ||
| Last updated 14.00pm 30/04/2024 ? | |||||
| MSB (ASX) Chart |